Related Experiment Video
Updated: Jul 30, 2025

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
Published on: March 24, 2023
Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective Study
Dan Slodownik1,2, Jonathan Bar1,2, Michal Solomon3
1From the Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Insights
Allergic contact dermatitis (ACD) in Israeli children is more common in females without atopic dermatitis. Acrylates are an emerging allergen, while methylisothiazolinone sensitivity is less frequent in those with atopic dermatitis.
Area of Science:
- Dermatology
- Pediatric Allergy
- Contact Dermatitis Research
Background:
- Allergic contact dermatitis (ACD) is prevalent in children, but data on Israeli pediatric populations is limited.
- Multicenter studies are needed to understand trends in pediatric contact sensitization in Israel.
Purpose of the Study:
- To describe and analyze patch test results and trends in Israeli children (0-18 years) across four tertiary care centers from 2012-2022.
- To identify demographic and atopic features associated with ACD and specific allergen sensitization.
- To investigate emerging allergens and trends in pediatric ACD within the Israeli population.
Main Methods:
- Retrospective analysis of 357 patch tests performed on children aged 0-18 years.
- Utilized the European baseline series and additional clinically indicated series.
- Assessed demographic data, atopic status, and patch test results, including allergen identification.
Main Results:
- Females constituted 69% of the study population, with higher sensitization rates (P<0.05).
- Patients without atopic dermatitis showed higher ACD diagnosis and patch test reactivity (P<0.05).
- Common allergens included preservatives and metals; acrylates emerged as a significant sensitizer, alongside potential emerging allergens like linalool hyperoxide. Fragrance mix 2 and Mroxylon pereirae were rare. Methylisothiazolinone sensitivity was less common in patients with atopic dermatitis (P<0.05).
Conclusions:
- ACD in Israeli children predominantly affects females without atopic dermatitis.
- Acrylates should be considered for inclusion in baseline patch test series due to increasing prevalence.
- Atopic dermatitis may confer a degree of protection against methylisothiazolinone sensitization.
Abstract:
Although allergic contact dermatitis (ACD) is relatively common in the adult and pediatric populations alike, few studies describe the special features of contact sensitization among the Israeli pediatric populations, none of them is multicenter. Our study aims to describe and analyze patch test results and trends in 4 tertiary care centers between 2012 and 2022. We assessed the results of 357 patch tests performed on children 0-18 years old between 2012 and 2022 in designated clinics in 4 tertiary medical centers. All patients were tested using the European baseline series and additional series as clinically indicated. We assessed the demographic features, atopic features, and influence, as well as the main allergens to cause sensitization and allergic contact dermatitis among the pediatric population. In total 69% of the study population were females, mainly 12-18 years old, 35% of the study population were previously diagnosed with atopic dermatitis, and 57% had an atopic diathesis. Females were more commonly sensitized (P < 0.05). Patients without atopic dermatitis were more commonly diagnosed with ACD and had more reactions on patch test (P < 0.05). The most common allergens to cause ACD are preservatives and metals, as previously described, however, acrylate sensitivity is an emerging group that has not been described among the Israeli pediatric population in previous studies. Fragrance mix 2 and Mroxylon pereirae are relatively rare allergens among the Israeli pediatric population, whereas linalool hyperoxide might be considered an emerging allergen. Methylisothiazolinone causes ACD more frequently among patients without atopic dermatitis (P < 0.05). Among the Israeli pediatric population, ACD is more common in females without atopic dermatitis. Acrylates become a common culprit and should be included in baseline series. Patients with atopic dermatitis are less frequently sensitized by methylisothiazolinone.

